GRP receptor blockade may serve as a broad spectrum of anti-inflammatory therapy for asthma [58,59], since reduced neutrophilic inflammation and cytokine production triggered by ozone were reduced with GRP blocking agent or antibody [53]. Here, GRP is linked to asthma.